Samuel George A. III sold LCTX
December 19, 2025 · Form 4 insider transaction
Samuel George A. III sold 65 shares of Lineage Cell Therapeutics, Inc. at $1.68 per share, a transaction worth $109.20. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
65
Price
$1.68
Total value
$109.20
InsiderSamuel George A. III
RoleOfficer
SecurityCommon Shares
Transaction codeF: Shares withheld for taxes
Transaction dateDecember 19, 2025
Filing dateDecember 19, 2025
Shares owned after27,490
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares withheld by the issuer to satisfy statutory tax withholding requirements on the vesting of 1,735 RSUs in a transaction exempt under Rule 16(b)-3. No shares were sold in connection with this transaction.; Does not include RSUs that may be settled in the issuer's common shares that have not vested as of the date hereof nor common shares that may be acquired upon the exercise of certain stock options outstanding as of the date hereof.